Revestive TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: teduglutide
Pack: Revestive (28 x 5 mg vials, 28 x 0.5 mL inert diluent syringes), 1 pack
Brand name
(ARTG)
: REVESTIVE teduglutide 5 mg powder for solution for injection vial with diluent pre-filled syringeDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
REVESTIVE is indicated for the treatment of adult and paediatric patients 2 years of age and above with Short Bowel Syndrome (SBS) who are dependent on parenteral support.,Patients should be stable for at least 4 weeks on their parenteral support regimen before initiating teduglutide therapy
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Subcutaneous
- White Powder
Component :
- Injection, solution
- Subcutaneous
- Clear liquid
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Do not Freeze
- Shelf lifetime is 4 Years.
Do I need a prescription ?
(ARTG)
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient teduglutide
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
